About PCSA Dividend Returns
Processa Pharmaceuticals, Inc. (PCSA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of PCSA over the past year?
Processa Pharmaceuticals, Inc. (PCSA) delivered a return of 295.26% over the past year. Since PCSA does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in PCSA be worth today?
A $10,000 investment in Processa Pharmaceuticals, Inc. one year ago would be worth $39,526 today, representing a gain of $29,526.
Q3Does PCSA pay dividends?
Processa Pharmaceuticals, Inc. (PCSA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PCSA, the total return equals the price-only return.
Q4Did PCSA beat the S&P 500?
Yes, Processa Pharmaceuticals, Inc. (PCSA) outperformed the S&P 500 by 279.81 percentage points over the past year. PCSA delivered a total return of 295.26%, compared to the S&P 500's 15.45%. This 279.81pp alpha means investors in PCSA earned more than a passive S&P 500 index fund.
Q5What is PCSA's worst drawdown?
Processa Pharmaceuticals, Inc. (PCSA) experienced a maximum drawdown of -97.79% over the past year, declining from its peak on 2025-12-12 to its trough on 2025-12-16. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is PCSA's long-term total return over 10, 20, or 30 years?
Processa Pharmaceuticals, Inc. (PCSA) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -96.1% (-27.8% CAGR) — $10,000 would have grown to $387. Over 20 years: -99.4% total return (-22.4% CAGR) — $10,000 → $62. Over 30 years: -99.4% total return (-15.6% CAGR) — $10,000 → $62. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was PCSA's best and worst year?
Processa Pharmaceuticals, Inc.'s best calendar year was 2017 with a total return of 1660.0%. Its worst year was 2024 with a total return of -87.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 1747.5 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).